VarmX

Biotech & Life Sciences · Leiden, Netherlands · Founded 2016

Developer of therapeutic drugs intended to restore blood clotting in bleeding patients. The company's drugs use modified recombinant human coagulation factor which is capable of restoring blood clotting in the presence of direct factor anticoagulants such as rivaroxaban, apixaban, and edoxaban, enabling physicians to safely and effectively restore hemostasis in case of bleeding. Keywords: Pharmaceuticals and BiotechnologyBiotech Drugs, Blood Clotting, Blood Clotting Treatment, Blood Coagulation, Hemostasis Medicine, Hemostasis Technology, Therapeutic Drug, Therapeutics Development.

Valuation $100–500M

Headcount <100

Total funding $50–100M

Unlock exact values

Investors

12 investors on VarmX's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage

UNIIQ

BioGeneration Ventures

InnovationQuarter Capital

European Innovation Council

Series A 7 investors entered at this stage

Inkef

Ysios Capital

EQT Life Sciences

Lundbeckfonden Ventures

EIC Fund

Sound Bioventures

Libertatis Ergo Holding

Series B+ 1 investor entered at this stage

Netherlands Enterprise Agency (RVO)

Global footprint

Where VarmX has talent and traffic

Workforce by country

5 countries with
team presence

🇳🇱 Netherlands56%

🇩🇰 Denmark16%

🇬🇧 United Kingdom12%

🇺🇸 United States12%

🇦🇹 Austria4%

5 countries shown

Talent graph

The shape of VarmX's talent

Dealroom maps VarmX's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

16 team members profilednamed & role-tagged by Dealroom

32 employeestotal headcount

5 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock VarmX's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about VarmX

An AI-synthesized read of the highest-engagement posts about VarmX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See VarmX on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles